NASDAQ: TNXP
Tonix Pharmaceuticals Holding Corp.CIK 0001430306 · Pharmaceutical Preparations
8-K
Filed May 27, 2026
· Period ending May 27, 2026
Tonix publishes Phase 1 results showing TNX-1500 blocked immune responses at all doses
3 material changes detected. Sign up free to read the summary.
8-K
Filed May 15, 2026
· Period ending May 15, 2026
Summary not yet generated.
Partner
Trade TNXP commission-free
Open an account, get a free stock.
Investing involves risk. Free stock terms apply.
8-K
Filed May 11, 2026
· Period ending May 11, 2026
Summary not yet generated.
10-Q
Filed May 11, 2026
· Period ending Mar 31, 2026
Summary not yet generated.
8-K
Filed May 7, 2026
· Period ending May 7, 2026
Summary not yet generated.
10-K
Filed Mar 12, 2026
· Period ending Dec 31, 2025
Summary not yet generated.
10-Q
Filed Nov 10, 2025
· Period ending Sep 30, 2025
Summary not yet generated.
10-K
Filed Mar 18, 2025
· Period ending Dec 31, 2024
Summary not yet generated.